Aligos Therapeutics, Inc. (ALGS)
6.91
-0.21
(-2.95%)
USD |
NASDAQ |
Feb 20, 15:20
Aligos Therapeutics Profit Margin (Quarterly) : -4.26K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 20.83% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Agenus, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -138.9% |
| Return on Assets | -77.83% |
| Return on Invested Capital | -123.7% |
| Gross Profit Margin (Quarterly) | 70.31% |
| Operating Margin (Quarterly) | -3.83K% |
| Return on Net Operating Assets | -1.28K% |